Oxford, UK – 6 August 2015: Oxford BioMedica plc (LSE: Oxford Biomedica), (“Oxford Biomedica” or “the Group”) a leading gene and cell therapy group, will be announcing its interim results for the six months ended 30 June 2015 on Thursday 27 August 2015 at 7am BST.
An analyst briefing will be held at 9:30am BST on 27 August 2015 at the offices of Consilium Strategic Communications: 41 Lothbury, EC2R 7HG. An audio replay will be made available shortly after the presentation on the Group’s website: www.oxfordbiomedica.co.uk.
